Page last updated: 2024-08-23

pravastatin and Acute Coronary Syndrome

pravastatin has been researched along with Acute Coronary Syndrome in 36 studies

Research

Studies (36)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	15 (41.67)	29.6817
2010's	21 (58.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cannon, CP; Guo, J; Khan, N; Steen, DL; Umez-Eronini, AA	1
Bare, LA; Devlin, JJ; Iakoubova, OA; Leahy, KJ; O'Sullivan, AK; Parthan, A; Weinstein, MC	1
Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Miyake, S; Morino, Y; Muramatsu, T; Nozato, T; Nozue, T; Onishi, Y; Sato, A; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T	1
Glasziou, PP; Irwig, L; Kirby, AC; Simes, RJ; Tonkin, AM	1
Cannon, CP; de Lemos, J; Guo, J; Lewis, EF; Mega, JL; O'Donoghue, ML; Rouleau, JL; Sabatine, MS; Sarma, A	1
Einecke, D	1
Li, L; Li, Y; Shen, J; Shen, Y; Su, F; Zhang, D; Zhang, M	1
Cannon, CP; Khera, AV; Murphy, SA; Qamar, A; Rader, DJ; Sabatine, MS	1
Bonaca, MP; Braunwald, E; Cannon, CP; Conrad, MJ; Jarolim, P; Morrow, DA; Murphy, SA; O'Malley, RG; Sabatine, MS; Scirica, BM; White, HD	1
Nambi, V; Polsani, VR; Virani, SS	1
Shen, J; Zhang, Q; Zhang, RY	1
Braunwald, E; Cairns, R; Cannon, CP; Morrow, DA; Ray, KK; Ridker, PM	1
Cannon, CP; Gibson, CM; McCabe, CH; Murphy, SA; Tung, P; Wiviott, SD	1
Brown, A; Cannon, CP; Mega, JL; Morrow, DA; Sabatine, MS	1
Boari, B; Manfredini, F; Manfredini, R; Salmi, R	1
Cannon, CP; Gibson, CM; Hochberg, CP; Pride, YB; Sabatine, MS; Sloan, S	1
Braunwald, E; Cannon, CP; McCabe, CH; Murphy, SA; Wiviott, SD	1
Acharjee, S; Cannon, CP; McCabe, C; Murphy, SA; Qin, J	1
King, S; Momary, K; Superko, HR	1
Cairns, R; Cannon, CP; Michael Gibson, C; Nazer, B; Ray, KK	1
Cannon, CP; Khera, AV; Qin, J; Rader, DJ; Wolfe, ML	1
Bangalore, S; Cannon, CP; Murphy, SA; Qin, J; Sloan, S	1
Braunwald, E; Cannon, CP; Morrow, DA; Nazer, B; Ray, KK; Scirica, B; Sloan, S	1
Caretta, G; Dei Cas, L; Della Pina, P; Gorga, E; Madureri, A; Raddino, R	1
Armani, A; Cannon, CP; McCabe, CH; Murphy, SA; Truong, QA	1
Cannon, CP; De Lemos, JA; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Wilson, SR; Wiviott, SD; Zhou, S	1
Braunwald, E; Cannon, CP; Grandin, EW; Jarolim, P; Morrow, DA; Murphy, SA; Ritterova, L	1
Bonaca, MP; Bui, AH; Cannon, CP; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS	1
Cannon, CP; Gibson, CM; Murphy, SA; Nazer, B; Ray, KK	1
Cannon, CP; Kumar, A	1
Han, YL; Kang, J; Li, CY; Li, Y; Yan, CH	1
Braunwald, E; Buros, J; Cannon, CP; Croce, K; Gao, H; Healy, AM; Libby, P; McCabe, CH; Morrow, DA; Pradhan, AD; Sabatine, MS; Sakuma, M; Simon, DI; Wang, Y	1
Blazing, M; Cannon, CP; Gersh, B; McLean, DS; Ravid, S; Shui, A	1
Braunwald, E; Cannon, CP; Miller, M; Murphy, SA; Qin, J; Ray, KK	1
Farmer, JA; Jones, PH	1
Glasziou, PP; Heritier, S; Irwig, L; Simes, RJ; Tonkin, A	1

Reviews

3 review(s) available for pravastatin and Acute Coronary Syndrome

Article	Year
[Indications for statin therapy in patients with acute coronary syndrome of ischemic origin]. Giornale italiano di cardiologia (2006), 2010, Volume: 11, Issue:10 Suppl 1 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Cholesterol; Electrocardiography; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Myocardial Infarction; Practice Guidelines as Topic; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention	2010
Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. Journal of interventional cardiology, 2007, Volume: 20, Issue:6 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Angiography; Coronary Disease; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Ultrasonography, Interventional	2007
Adjunctive interventions in myocardial infarction: the role of statin therapy. Current atherosclerosis reports, 2008, Volume: 10, Issue:2 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Coronary Circulation; Coronary Occlusion; Dyslipidemias; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic	2008

Trials

29 trial(s) available for pravastatin and Acute Coronary Syndrome

Article	Year
The effect of fasting status on lipids, lipoproteins, and inflammatory biomarkers assessed after hospitalization for an acute coronary syndrome: Insights from PROVE IT-TIMI 22. Clinical cardiology, 2018, Volume: 41, Issue:1 Topics: Acute Coronary Syndrome; Atorvastatin; Biomarkers; Colorimetry; Dose-Response Relationship, Drug; Fasting; Female; Follow-Up Studies; Hospitalization; Humans; Immunoturbidimetry; Inflammation; Lipids; Lipoproteins; Male; Middle Aged; Pravastatin; Prognosis; Retrospective Studies	2018
Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndrome. PharmacoEconomics, 2013, Volume: 31, Issue:6 Topics: Acute Coronary Syndrome; Atorvastatin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Genetic Testing; Genotype; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinesins; Male; Markov Chains; Middle Aged; Molecular Targeted Therapy; Pravastatin; Pyrroles; Quality-Adjusted Life Years	2013
Comparison of the effects of pitavastatin versus pravastatin on coronary artery plaque phenotype assessed by tissue characterization using serial virtual histology intravascular ultrasound. Heart and vessels, 2015, Volume: 30, Issue:1 Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Necrosis; Phenotype; Plaque, Atherosclerotic; Pravastatin; Prospective Studies; Quinolines; Ultrasonography, Interventional	2015
Which lipid measurement should we monitor? An analysis of the LIPID study. BMJ open, 2014, Feb-21, Volume: 4, Issue:2 Topics: Acute Coronary Syndrome; Adult; Aged; Australia; Female; Finland; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Longitudinal Studies; Male; Mass Screening; Middle Aged; New Zealand; Pravastatin	2014
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome. Journal of the American Heart Association, 2014, May-01, Volume: 3, Issue:3 Topics: Acute Coronary Syndrome; Acute Kidney Injury; Atorvastatin; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pravastatin; Pyrroles	2014
[IMPROVE-IT Study proves effectiveness of ezetimib. The Higgs particle of lipidologists]. MMW Fortschritte der Medizin, 2014, Dec-15, Volume: 156, Issue:21-22 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Pravastatin; Pyrroles; Simvastatin	2014
Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes. Lipids in health and disease, 2015, Feb-18, Volume: 14 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; China; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Rosuvastatin Calcium; Simvastatin	2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study). The American journal of cardiology, 2015, Sep-01, Volume: 116, Issue:5 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Leptin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pravastatin; Pyrroles; Recurrence; Resistin; Retrospective Studies; Risk Factors; Survival Rate; Thrombolytic Therapy; United States	2015
Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease. Journal of the American College of Cardiology, 2016, 07-19, Volume: 68, Issue:3 Topics: Acute Coronary Syndrome; Atorvastatin; Biomarkers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Troponin I	2016
[Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina]. Zhonghua xin xue guan bing za zhi, 2008, Volume: 36, Issue:9 Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angina Pectoris; Atorvastatin; Clopidogrel; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pravastatin; Prospective Studies; Pyrroles; Ticlopidine	2008
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:3 Topics: Acute Coronary Syndrome; Apolipoprotein A-I; Apolipoproteins B; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Proportional Hazards Models; Pyrroles; Recurrence; Risk Assessment; Time Factors; Treatment Outcome	2009
Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE The American journal of cardiology, 2009, Apr-15, Volume: 103, Issue:8 Topics: Acute Coronary Syndrome; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Seasons	2009
Identification of genetic variants associated with response to statin therapy. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:9 Topics: Acute Coronary Syndrome; Apolipoproteins E; Atorvastatin; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cholesterol, LDL; Haplotypes; Heptanoic Acids; Heterozygote; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Phenotype; Polymorphism, Genetic; Practice Guidelines as Topic; Pravastatin; Pyrroles; Treatment Outcome	2009
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis I Journal of the American College of Cardiology, 2009, Dec-08, Volume: 54, Issue:24 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atorvastatin; Cardiovascular Diseases; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Pyrroles	2009
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection T Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrroles; Regression Analysis; Secondary Prevention; Stroke	2009
Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial). The American journal of cardiology, 2010, Mar-01, Volume: 105, Issue:5 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Cholesterol; Cohort Studies; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrroles; Risk Factors; Stroke; Treatment Outcome	2010
Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes. Journal of thrombosis and thrombolysis, 2010, Volume: 30, Issue:1 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atherosclerosis; Atorvastatin; C-Reactive Protein; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Observation; Pravastatin; Pyrroles; Treatment Outcome	2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study). The American journal of cardiology, 2010, Aug-15, Volume: 106, Issue:4 Topics: Acute Coronary Syndrome; Atorvastatin; C-Reactive Protein; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Risk Factors; Triglycerides	2010
What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TI Circulation, 2010, Nov-23, Volume: 122, Issue:21 Topics: Acute Coronary Syndrome; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Pressure; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypertension; Incidence; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prognosis; Proportional Hazards Models; Pyrroles; Risk Factors; Thrombolytic Therapy; Treatment Outcome	2010
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. European heart journal, 2011, Volume: 32, Issue:11 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Male; Middle Aged; Neopterin; Pravastatin; Proportional Hazards Models; Pyrroles; Sensitivity and Specificity; Treatment Outcome	2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circulation. Cardiovascular quality and outcomes, 2011, Volume: 4, Issue:3 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Sex Characteristics; Stroke; Treatment Outcome	2011
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PR American heart journal, 2011, Volume: 161, Issue:6 Topics: Acute Coronary Syndrome; Adiponectin; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Female; Heart Failure; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Recurrence; Risk Assessment	2011
Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:2 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Placenta Growth Factor; Pravastatin; Pregnancy Proteins; Pyrroles; Risk Factors	2012
Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy. Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:3 Topics: Acute Coronary Syndrome; Aged; Albuminuria; Anticholesteremic Agents; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors	2013
[The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:9 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Clopidogrel; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Prospective Studies; Pyrroles; Ticlopidine	2007
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial American heart journal, 2008, Volume: 155, Issue:1 Topics: Acute Coronary Syndrome; Aged; Anti-Infective Agents; Atorvastatin; Biomarkers; Calgranulin A; Calgranulin B; Case-Control Studies; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pravastatin; Probability; Pyrroles; Reference Values; Risk Assessment; Survival Rate; Thrombolytic Therapy; Treatment Outcome	2008
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. American heart journal, 2008, Volume: 155, Issue:2 Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Atorvastatin; Atrial Fibrillation; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Pravastatin; Pyrroles; Thrombolytic Therapy; Tirofiban; Tyrosine	2008
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2008, Feb-19, Volume: 51, Issue:7 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Risk Assessment; Triglycerides	2008
Monitoring cholesterol levels: measurement error or true change? Annals of internal medicine, 2008, May-06, Volume: 148, Issue:9 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Cholesterol; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Pravastatin; Time Factors	2008

Other Studies

4 other study(ies) available for pravastatin and Acute Coronary Syndrome

Article	Year
Lipid management: considerations in acute coronary syndrome. Current cardiology reports, 2008, Volume: 10, Issue:4 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Risk Assessment; Risk Factors; Triglycerides	2008
Seasonal variation in lipids: should we consider it more? The American journal of cardiology, 2009, Sep-01, Volume: 104, Issue:5 Topics: Acute Coronary Syndrome; Atorvastatin; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pravastatin; Pyrroles; Seasons	2009
Statins in acute coronary syndromes and genetic insight. Journal of the American College of Cardiology, 2010, Mar-23, Volume: 55, Issue:12 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pyrroles; Treatment Outcome	2010
Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clinical chemistry, 2012, Volume: 58, Issue:1 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Case-Control Studies; Female; Galectin 3; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Pravastatin; Prognosis; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors	2012